Health effects and bioavailability of dietary flavonols

Free Radical Research

Volumn 31, Issue SUPPL., 1999, Pages

  Hollman, Peter C H ^a   Katan, Martijn B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antioxidants; Bioavailability; Dietary flavonoids; Epidemiology; Flavonol glycosides; Flavonols

Indexed keywords

CATECHIN; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; ISOFLAVONE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG STRUCTURE; FEMALE; GROWTH INHIBITION; HEALTH FOOD; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; TUMOR GROWTH;

EID: 0033387699     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769900301351     Document Type: Conference Paper

References (25)

1. World Cancer Research Fund/American Institute for Cancer Research (1997). Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC.
2. A.R. Ness and J.W. Powles (1997). Fruit and vegetables, and cardiovascular disease: a review. International Journal of Epidemiology 26, 1-13.
3. E. Middleton and C. Kandaswami (1994). The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In The Flavonoids: Advances in Research Since 1986 (Ed. Harborne, J.B.), Chapman & Hall, London, pp. 619-652.
4. B. Halliwell (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? The Lancet 344, 721-724.
5. C.A. Rice-Evans and N.J. Miller (1996). Antioxidant activities of flavonoids as bioactive components of food. Biochemical Society Transactions 24, 790-795.
6. D. Steinberg (1997). Lewis A. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation 95, 1062-1071.
7. K. Konda, A. Matsumoto, H. Kurata, H. Tanahashi, H. Koda, T. Amachi and H. Itakura (1994). Inhibition of oxidation of low-density lipoprotein with red wine. The Lancet 344, 1152.
8. M.G.L. Hertog, P.C.H. Hollman and M.B. Katan (1992). Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry 40, 2379-2383.
9. M.G.L. Hertog, P.C.H. Hollman and B. van de Putte (1993). Content of potentially anticarcinogenic flavonoids of tea infusions wines, and fruit juices. Journal of Agricultural and Food Chemistry 41, 1242-1246.
10. J. Kühnau (1976). The flavonoids. A class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics 24, 117-191.
11. M.G.L. Hertog, P.C.H. Hollman, M.B. Katan and D. Kromhout (1993). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer 20, 21-29.
12. M.G.L. Hertog, E.J.M. Feskens, P.C.H. Hollman, M.B. Katan and D. Kromhout (1994). Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutrition and Cancer 22, 175-184.
13. R.A. Goldbohm, P.A. van den Brandt, M.G.L. Hertog, H.A.M. Brants and G. van Poppel (1995). Flavonoid intake and risk of cancer: a prospective cohort study. American Journal of Epidemiology, 141(Suppl.), s61.
14. P. Knekt, R. Järvinen, R. Seppänen, M. Heliövaara, L. Teppo, E. Pukkala and A. Aromaa (1997). Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. American Journal of Epidemiology 146, 223-230.
15. M.G.L. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljkovic, M. Pekkarinen, B.S. Simic, H. Toshima, E.J.M. Feskens, P.C.H. Hollman and M.B. Katan (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Archives of Internal Medicine 155, 381-386.
16. M.G.L. Hertog, E.J.M. Feskens, P.C.H. Hollman, M.B. Katan and D. Kromhout (1993). Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet 342, 1007-1011.
17. M.G.L. Hertog, E.J.M. Feskens and D. Kromhout (1997). Antioxidant flavonols and coronary heart disease risk. The Lancet 349, 699.
18. S.O. Keli, M.G.L. Hertog, E.J.M. Feskens and D. Kromhout (1996). Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen study. Archives of Internal Medicine 156, 637-642.
19. P. Knekt, R. Järvinen, A. Reunanen and J. Maatela (1996). Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal 312, 478-481.
20. E.B. Rimm, M.B. Katan, A. Ascherio, M.J. Stampfer and W.C. Willett (1996). Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Annals of Internal Medicine 125, 384-389.
21. M.G.L. Hertog, P.M. Sweetnam, A.M. Fehily, P.C. Elwood and D. Kromhout (1997). Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. The American Journal of Clinical Nutrition 65, 1489-1494.
22. K.H. van het Hof, G.A.A. Kivits, J.A. Weststrate and L.B.M. Tijburg (1998). Bioavailability of catechins from tea: the effect of milk. European Journal of Clinical Nutrition 52, 356-359.
23. M.B. Katan (1997). Flavonoids and heart disease. The American Journal of Clinical Nutrition 65, 1542-1543.
24. P.C.H. Hollman, J.H.M. de Vries, S.D. van Leeuwen, M.J.B. Mengelers and M.B. Katan (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. The American Journal of Clinical Nutrition 62, 1276-1282.
25. P.C.H. Hollman, J.M.P. van Trijp, M.N.C.P. Buysman, M.S. van der Gaag, M.J.B. Mengelers, J.H.M. de Vries and M.B. Katan (1997). Relative bioavailability of the antioxidant quercetin from various foods in man. FEBS Letters 418, 152-156.